Open access
Aug 2026
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.
This approach identified a unique peptide corresponding to FGFR2b, a splicing isoform of FGFR2, that demonstrated markedly higher tumor enrichment than the alternative FGFR2 isoform, FGFR2c.
N. Shah, Beatriz Alvarado-Hernandez, Xinyue Chen et al.
· Clinical Cancer Research · 0 citations